Company ProfilePremium

Icelandic Salmon AS

Company Profile Analysis

Ticker: ISLAX.OL

ESOMAR 23 Corporate BadgeISO Certifications Badge
Icelandic Salmon AS - Company showcase

Year Founded & Workforce

2009

177 Employees

Icelandic Salmon AS logo

Icelandic Salmon AS Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Icelandic Salmon AS Overview

Icelandic Salmon AS is a Norwegian-incorporated holding company whose sole operating asset, Arnarlax ehf., is one of Iceland's two largest Atlantic salmon farmers and historically the country's largest by harvest volume. Controlled by SalMar ASA (52.5%), the world's second-largest salmon farmer, it operates a fully integrated egg-to-market value chain in the Westfjords and on Iceland's south coast: four smolt facilities, sea farms in Arnarfjörður, Patreksfjörður and Tálknafjörður under 23,700 tonnes of maximum allowed biomass (MAB), a 30,000-tonne harvesting plant in Bíldudalur, and an in-house sales organisation shipping fresh salmon to Europe, North America and Asia. After record years in 2022–2023 (16–18 thousand tonnes harvested; operational EBIT up to EUR 36m), the group suffered two years of biological setbacks, a licence revocation and losses. 2026 is positioned as a recovery year (21,300 tonnes guided), but regulatory and fiscal uncertainty in Iceland has led management to freeze its 26,000-tonne growth plan.


Company's own description (paraphrased from 1H 2026 report and Q2 2026 presentation): Icelandic Salmon AS is the sole owner and parent of Arnarlax ehf., through which all operating activities are carried out. The group describes itself as fully integrated: it procures salmon eggs for its hatcheries, produces its own smolt and post-smolt, farms salmon in sea pens, harvests and processes in its own plant, and sells and distributes "sustainable Icelandic salmon" through an internal sales department to Europe, North America and the Far East. The stated purpose is the production, processing and sale of seafood and seafood-based products. The group reports a single operating segment.

Business model. The business is a biologically driven commodity-producer model. Value is created by converting purchased eggs and feed into harvestable salmon over a roughly 2.5–3-year production cycle (approximately 12–18 months in freshwater/post-smolt plus 12–20 months at sea), constrained by regulatory MAB licences. Revenue is a function of harvest volume × achieved price; profitability is a function of the spread between achieved price and full production cost per kg (feed, smolt, sea-lice treatment, mortality, harvesting, freight, production tax).

Revenue model mix (FY2025 and 1H 2026, EUR thousands):

Product sales account for over 99% of revenue. There is no subscription or licensing income. Fixed-price contract share is low (6% in Q2 2026; 10% expected for FY2026), so the company is highly exposed to spot salmon prices (source: Q2 2026 presentation).

Value chain position. Upstream: purchases eggs (currently from Benchmark Genetics' Icelandic operation StofnFiskur; applications filed in Sept 2026 to add Norway's AquaGen as an approved source) and feed (supplier not disclosed). Midstream: owns smolt production, sea farming and primary processing (harvest plant). Downstream: sells primarily head-on gutted fresh salmon to importers, processors, wholesalers and retail-linked buyers; it does not operate significant secondary processing or consumer brands at retail scale.

Customer types. Seafood importers/distributors, secondary processors (fillet and smoked salmon producers), wholesale and food-service channels in Europe; importers serving US retail/food-service; Asian importers (China notably cited) buying larger fish. Specific customer names are not publicly disclosed. Normal credit terms are 21 days (1H 2026 report, Note 2).

End-markets (share of fish-sales revenue, company data):

(Source: 1H 2026 report key-figures page. 2023 Asia derived as residual. The same report's Note 2 shows FY2025 as 67/15/17 and the presentation chart shows 1H 2026 as 65/15/20 — rounding discrepancies.)

Independent characterisation. Icelandic Salmon is best understood as a sub-scale but structurally advantaged single-country salmon producer that sits inside SalMar's operating system. Its advantages — low-lice cold waters by Norwegian standards, geothermal-assisted smolt production, proximity to US and European airfreight lanes through Keflavík, and a premium "Icelandic origin" narrative — are offset by Iceland's harsh winter conditions (winter ulcers, storms), an immature and politically contested regulatory regime, a rising resource tax, and a concentrated licence base of only three fjords. Earnings are extremely volatile: operational EBIT swung from EUR 36.2m (2022) to minus EUR 18.2m (2025) on broadly similar revenue scale, illustrating how biology and cost-per-kg dominate the P&L. The equity story since 2024 has shifted from "Iceland growth platform" to "operational recovery under regulatory uncertainty."

Strategy

Stated strategy themes (paraphrased from 1H 2026 report and annual reports)

  1. Sustainable growth "on the salmon's terms" — growth in harmony with nature; 100% ASC-certified sea production and BRCGS-certified harvesting.

  2. Full value-chain control — self-sufficiency in smolt and post-smolt; own harvesting capacity in Bíldudalur; all sales through an in-house department.

  3. Post-smolt strategy — larger smolts (130–700 g; 5.1m smolts planned for release in 2026) to shorten sea time and improve survival through the first winter.

  4. Low-cost producer ambition — combining biological best practice with cost efficiency; ongoing cost-saving programme.

  5. Licence-base expansion — re-obtain 10,000 t sterile-salmon licence in Ísafjarðardjúp; expand five Arnarfjörður sites.

  6. Leadership in Iceland's aquaculture industry — stated aim to be the leader of the sector and a contributor to local communities.

  7. Culture and organisation — values of leadership in salmon farming, quality, teamwork and care.

Strategic initiatives (last 24 months)

InitiativeDateDescriptionStatus / targets
Cost-saving programme2025–H2 2026Group-wide initiatives; positive effect on operational cost reported in H1 2026Continuing into H2 2026; no quantified target disclosed
Growth plan to 26,000 tAnnounced 2024–25; on hold Aug 2026Targeted long-term investment plan to fully utilise production capacity (26 kt)Frozen due to regulatory uncertainty; FY2026 capex cut to EUR 4.1m
Laxabraut post-smolt facilityOngoingSouth-coast post-smolt expansionCompletion expected Q1 2027
Non-medicinal lice controlJune 2026Service vessel with FLS delicing system operational; complements Stingray lasers and lice skirts; medicinal treatment minimisedOperational
Genetics diversificationSept 2026MAST proposed licence amendments adding AquaGen as an approved egg source for two Arnarlax facilities, Fjallalax (Hallkelshólar) and Ísþór (Þorlákshöfn)Consultation closed 7 Oct 2026; final decision pending
Ísafjarðardjúp sterile salmon2024–ongoingRe-approval of 10,000 t MAB sterile-salmon licence (three sites)"Significant progress" in 2026; timing undetermined
Arnarfjörður expansion2,026Application to expand five existing sitesTiming undetermined
Sales platform monetisationH1 2026Third-party producer outsourced sales to ArnarlaxOngoing
Market-mix shift2025–26Growing Asia/North America share via larger fishAsia 21% of H1 2026 revenue
EU customs adaptationNov 2024Arnarlax Europe ApS for in-transit salesOperational
Sustainability-linked financing2023–25EUR 100m SLL (2023), upsized to EUR 160m (2025), amended Sept 2025KPIs not disclosed in sources reviewed

Management guidance / medium-term targets

ItemGuidanceSource
Harvest volume FY202621,300 tonnes (unchanged since Q4 2025 report; initially 21,000 t at Q3 2025)Q2 2026 presentation
Cost levelLower in Q3 2026 vs Q2 2026 as 2025 generation harvesting beginsQ2 2026 presentation
MAB utilisationBetter in 2026, positive cost effectQ2 2026 presentation
Contract share FY2026About 10%Q2 2026 presentation
Capex FY2026EUR 4.1mQ2 2026 earnings summary
Long-term volume potential26,000 t on existing licences (smolt capacity for 25–30 kt) — now on hold1H 2026 report; Annual Report 2024
Financial targets (margin, ROCE)——

Products & Services

The group is a mono-product producer. The catalogue below lists every product and service category disclosed or evidenced.

Note: one aggregator (roic.ai) describes smoked-salmon products and processing partnerships in Ireland and Spain.

Product Portfolio

#Product / serviceDescription & specificationsTarget customerLaunch / latestPricing model
1

Fresh whole Atlantic salmon, head-on gutted (HOG)

Core product; harvested and packed at Bíldudalur; graded by weight class; fresh on ice, shipped by truck/ferry to Europe and by air to US/Asia

Importers, processors, wholesalers

Ongoing

Predominantly spot, referenced to market prices (e.g., NASDAQ/SISALMON, Fish Pool); 6% fixed contracts in Q2 2026, 10% expected FY2026

2

Large-size salmon (6+ kg)

Premium size class; drove higher North America (16%) and Asia (19%) volume shares in Q2 2026

US and Chinese buyers of large fish

Ongoing

Spot, size premium

3

Fresh salmon fillets

Company reported rising demand for fillets in 2022 (Q4 2022 release); current volumes not disclosed

US / European buyers

c.2022

—
4

Frozen salmon / downgraded fish

Frozen whole salmon and lower-grade fish (e.g., after biological incidents) listed in inventory categories

Processors

Ongoing

Spot, discount to superior grade

5

"Arnarlax – Sustainable Icelandic Salmon" brand

Common brand for all products, launched 2021; origin and sustainability positioning (ASC, BRCGS)

Trade buyers, retail partners

2,021

Brand premium not quantified

6

Harvesting services

Third-party harvesting at Bíldudalur (plant capacity 30 kt vs own 21 kt guided volume)

Other Westfjords farmers

Ongoing

Fee-based; within "other revenues" (EUR 0.5m FY2025)

7

Sales and marketing services

Since H1 2026, a third-party salmon producer has outsourced its sales to the Arnarlax sales team

Other Icelandic producers

2,026—
8

Sludge sales

Sale of aquaculture sludge to processing companies

Processors (fertiliser/biogas)

Ongoing

—
9

Employee accommodation leasing

Rental income from staff housing

Employees

Ongoing

Lease

10

Arctic char (legacy)

Biological asset category still includes "arctic char fish at cost" (Fjallalax origin)

—

Legacy

—

“—” = not publicly disclosed.

Financial Narrative

Income statement

Sources: 1H 2026 report (multi-year key figures, FY2025 income statement and APM note); Q4 2022 release (FY2021–22 operational EBIT/kg). FY2023–24 operational EBIT/kg, revenue/kg, gross profit, operational EBITDA (operational EBIT + D&A of EUR 13.9m) and CAGR derived. Dividends: no ordinary dividend paid for financial years 2021–2025 (ex-dividend entries of NOK 0.00 each year; AGM 2026 resolved no dividend for 2025).

Margins (%):

(Derived from figures above.)

FY2025 income statement detail (EUR thousands; Annual Report 2025 comparatives in 1H 2026 report):

Note the presentation: the income tax line is shown as negative EUR 9.0m while net loss (EUR 24.8m) is smaller than pre-tax loss (EUR 33.8m), meaning the tax line represents a tax income (deferred tax benefit) of approximately EUR 9.0m despite the sign shown. The same applies to H1 2026 (tax effect EUR 2.2m).

Commentary — income statement. The five-year arc is a boom-and-bust in volume and unit margin. Revenue rose 73% in 2022 on +40% harvest and strong prices, and edged up in 2023 to a peak of EUR 164.8m on record volume. Operational EBIT, however, peaked a year earlier (2022, EUR 36.2m, EUR 2.24/kg) and halved in 2023 as costs rose and the Q4 2023 Tálknafjörður lice crisis forced early harvests. The 2024 collapse (harvest −35%, revenue −38%) reflected biological losses in the winter of 2023–24 and the deliberate holding back of biomass. 2025 was worse on margin despite +9% volume: all Q2–Q3 2025 harvest came from the high-cost 2023 generation, extraordinary biological costs were recognised, and achieved revenue per kg fell to about EUR 7.10 amid weaker global prices. The inflection is visible from Q4 2025 (operational EBIT +EUR 0.70/kg) and Q1 2026 (near break-even), with Q2 2026 again negative (−EUR 0.59/kg) due to BKD at one site from the 2024 generation (EUR 2.2m extraordinary cost in the quarter, EUR 3.0m YTD). The decisive driver for the next 12 months is whether the well-performing 2025 generation, harvested from Q3 2026, delivers the lower cost per kg management expects.

Balance sheet

Sources: 1H 2026 report key-figures charts (assets, equity ratio, NIBD, leases, biomass), FY2025 balance sheet, statement of changes in equity (equity 1 Jan 2025 = EUR 149.8m), Q4 2022 release (equity 2022 EUR 144m, up EUR 35m from 2021). FY2025 net working capital derived as current assets ex cash (122.8) minus non-interest-bearing current liabilities (17.0) — note current liabilities include EUR 7.9m of current debt/leases which are excluded. FY2023 equity not directly verified (equity ratio × assets would imply approx. EUR 152m, shown as n/a to avoid estimation). The FY2025 equity ratio is 45% in the key-figure chart but "47%" in the narrative text; arithmetic (124.98/278.36) gives 44.9%.

Commentary — balance sheet. The balance sheet has been levered up to finance biomass rebuilding and smolt-capacity investment while earnings turned negative. NIBD ex-leases rose from EUR 45.8m (2023) to EUR 116.6m (2025) — a 2.5x increase — while equity fell by about EUR 25m in 2025 alone. The equity ratio dropped from 64% to 45% (43% at 30 June 2026), uncomfortably closer to the 35% covenant floor. Biological assets are the dominant current asset (EUR 109.5m at YE2025), meaning the balance sheet is exposed to fair-value swings driven by forward salmon prices and to incident-based mortality write-downs. Goodwill of EUR 34.7m (from historical combinations, primarily the Fjarðalax transaction) represents 28% of equity. Licences are carried at only EUR 1.7m — far below economic value, as Icelandic licences were largely granted rather than purchased — implying meaningful hidden asset value if licences are ever transacted.

Cash flow

Sources: Annual Report 2025 via 1H 2026 report cash-flow comparatives; FCF derived. No dividends or buybacks were executed in the period (AGM records; no buyback execution disclosed).

Commentary — cash flow. 2025 was a heavy cash-burn year: operating cash flow was negative EUR 22.1m as EUR 18.5m was absorbed into biomass at cost (closing biomass rose to 18.1kt lwt from 12.8kt), plus negative operating earnings. The deficit was financed by EUR 45m of new bank drawings. H1 2026 marks a clear inflection: operating cash flow turned positive (EUR 13.4m) as biomass was harvested down (biological assets fell EUR 11.9m) and price achievement improved, while capex was cut to EUR 1.6m (full-year 2026 plan EUR 4.1m, down from earlier growth-plan levels). NIBD fell by EUR 7m in Q2 2026 alone. The sustainability of positive FCF depends on margins rather than working-capital release, as biomass will need to be rebuilt for 2027 harvests.

Ratios

Derived by analyst. ROE = net income / average equity (149.8, 125.0); ROA = net income / average assets (263.2, 278.4); ROIC approximated as operational EBIT (pre-tax) / average (equity + NIBD incl. leases); net debt/EBITDA not meaningful in FY2025 as operational EBITDA was negative. Cash conversion cycle: not meaningful/not disclosed — for salmon farmers the economic cycle is dominated by a 2–3-year biomass build, not receivables/payables.

Commentary — ratios. Returns were deeply negative in 2025. The high current ratio is misleading: it reflects biomass carried as a current asset, not liquidity (cash was only EUR 7.3m at YE2025; available liquidity, including undrawn facilities, was EUR 46m at 30 June 2026 and EUR 52m at 30 Sept 2025). Leverage relative to equity has more than doubled since 2023. Interest coverage was negative in 2025, which is why the original ICR and leverage covenants had to be waived.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRegistered officeOwnerOwnershipFunction

Icelandic Salmon AS

Kverva, Norway

Listed; SalMar 52.48%

—

Listed holding company

Arnarlax ehf.

Strandgata 1, 465 Bíldudalur, Iceland

Icelandic Salmon AS

100%

All operations: farming, harvesting, sales

Fjallalax ehf.

Bíldudalur (site at Hallkelshólar, south Iceland)

Arnarlax ehf.

100%

Geothermal smolt facility; 100 t MAB; approx. 1.3m smolts/yr

Eldisstöðin Ísþór ehf.

Nesbraut 25, 815 Þorlákshöfn

Arnarlax ehf.

100%

Smolt/large-smolt facility; 2,700 t MAB; 3.3–4.0m smolts/yr at 130–700 g

Icelandic Salmon ehf.

Bíldudalur

Arnarlax ehf.

100%

Dormant; retained to preserve name rights

Arnarlax Europe ApS

Lautrupsgade 11, Copenhagen

Arnarlax ehf.

100%

EU entity enabling in-transit sales under EU customs rules

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2023FY2024FY2025

Segment revenue (EUR Mn)

164.8101.590.0

Segment operational EBIT (EUR Mn)

20.3-5.9-18.2

Operational EBIT margin (%)

12.3-5.8-20.2

Revenue YoY growth (%)

4.6-38.4-11.3

Share of group revenue (%)

100100100

Harvest volume (thousand tgw)

17.911.712.7

Operational EBIT per kg (EUR)

1.13-0.50-1.44

Function Details

FunctionAssetsCapacity

Smolt

Gileyri (Westfjords), Ísþór (Þorlákshöfn), Fjallalax (Hallkelshólar), Laxabraut 5 (south coast; post-smolt expansion due Q1 2027)

Sufficient for 25–30 kt harvest

Seawater

Sites in Arnarfjörður, Patreksfjörður, Tálknafjörður

23,700 t MAB; 6–8 sites (company documents vary: "six", "seven ASC-certified", "eight")

Harvesting

Bíldudalur plant, BRCGS-certified

30,000 t/yr

Sales

In-house sales team; Arnarlax Europe ApS

Domestic and global

Revenue by Segment and Unit Economics (EUR/kg)

MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue (EUR Mn)

10.525.025.129.426.939.9

Operational EBIT (EUR Mn)

-3.0-8.3-9.42.6-0.1-3.2

Harvest (thousand tgw)

1.14.03.83.83.75.5

Operational EBIT per kg (EUR)

—-2.09-2.480.70-0.02-0.59

Income Statement and Unit Economics (EUR/kg)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (EUR Mn)

90.8157.6164.8101.590.0

Harvest volume (thousand tgw)

11.516.117.911.712.7

Revenue per kg harvested (EUR)

7.909.799.218.687.10

Gross profit after COGS (EUR Mn)

————31.9

Operational EBIT (EUR Mn)

7.336.220.3-5.9-18.2

Operational EBIT per kg (EUR)

0.632.241.13-0.50-1.44

Operational EBITDA (EUR Mn)

————-4.3

Production tax (EUR Mn)

————-3.9

Fair value adjustment of biomass (EUR Mn)

————-2.8

Operating profit IFRS (EUR Mn)

————-25.2

Net financial items (EUR Mn)

————-8.6

Pre-tax income (EUR Mn)

————-33.8

Net income (EUR Mn)

————-24.8

EPS basic and diluted (EUR)

————-0.80

Dividend per share (NOK)

—0000

Revenue CAGR FY2021–FY2025 (%)

————-0.2

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin after COGS (%)

————35.5

Operational EBIT margin (%)

8.023.012.3-5.8-20.2

Operational EBITDA margin (%)

————-4.8

Net margin (%)

————-27.6

Business Lines

LineFY2025

Total operating revenue

89,976

Cost of goods sold

(58,058)

Salaries and personnel

(17,050)

Other operating expenses

(19,173)

Depreciation and amortisation

(13,886)

Restructuring cost

(369)

Production tax

(3,873)

Fair value adjustment of biomass

(2,777)

Operating profit

(25,210)

Financial income

362

Financial expense

(8,926)

Net currency gain/(loss)

(45)

Profit before tax

(33,819)

Income tax

(9,005)

Net profit

(24,813)

Balance Sheet and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (EUR Mn)

171.0235.3238.3263.2278.4

Equity ratio (%)

6461645745

Total equity (EUR Mn)

109144—149.8125.0

Cash and equivalents (EUR Mn)

———6.97.3

Interest-bearing debt to banks (EUR Mn)

————123.9

— of which short-term (EUR Mn)

————3.0

— of which long-term (EUR Mn)

————120.9

Net interest-bearing debt ex leases (EUR Mn)

36.856.045.875.6116.6

Lease liabilities (EUR Mn)

5.96.95.711.212.4

NIBD incl. leases (EUR Mn)

42.763.051.586.8129.0

Goodwill (EUR Mn)

————34.7

Licences (intangible, EUR Mn)

————1.7

Biological assets (EUR Mn)

————109.5

Closing biomass (thousand t lwt)

14.014.99.612.818.1

Net working capital ex cash (EUR Mn)

————105.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (EUR Mn)

————-22.1

Capex (EUR Mn)

————-6.5

Free cash flow (EUR Mn)

————-28.6

Dividends paid (EUR Mn)

00000

Share buybacks (EUR Mn)

00000

New interest-bearing debt drawn (EUR Mn)

————45.0

Debt repayments (EUR Mn)

————-3.0

Lease principal paid (EUR Mn)

————-4.6

Interest paid (EUR Mn)

————-8.5

Cash Flow (Half-Yearly)

MetricH1 2025H1 2026

Operating cash flow (EUR Mn)

-10.813.4

Capex (EUR Mn)

-5.7-1.6

Free cash flow (EUR Mn)

-16.511.8

Net financing cash flow (EUR Mn)

14.8-8.6

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2024FY2025

ROE (%)

———-18.1

ROA (%)

———-9.2

ROIC operational EBIT based (%)

———-7.4

Current ratio (x)

———5.2

Debt to equity incl. leases (x)

———1.09

Interest coverage operational EBIT/financial expense (x)

———-2.0

Asset turnover (x)

———0.33

NIBD incl. leases to equity (x)

0.390.440.581.03

Revenue by Region

RegionFY2023FY2024FY2025

Europe (EUR Mn)

123.669.060.6

North America (EUR Mn)

31.316.213.8

Asia (EUR Mn)

9.916.215.5

Total (EUR Mn)

164.8101.590.0

Revenue by Region (%)

RegionFY2024 YoYFY2025 YoY

Europe (%)

-44.2-12.2

North America (%)

-48.2-14.8

Asia (%)

63.6-4.3

Revenue by Region (Half-Yearly)

RegionH1 2025H1 2026Growth (%)

Europe (EUR Mn)

27.243.259.1

North America (EUR Mn)

4.89.6100.1

Asia (EUR Mn)

3.513.8292.2

Valuation Snapshot

MetricValueSource / note

Recent share price

approx.

Alphaspread; roic.ai

Price at 30 Jun 2026

NOK 66.0

1H 2026 report

Price at start of 2026

NOK 79 (−16.5% YTD to end June)

1H 2026 report

Price 3 Oct 2025

NOK 88.40

Simply Wall St

52-week change

approx. −30%

roic.ai

Oct 2020 placement price

NOK 115

Fish Farming Expert

Market capitalisation

approx. NOK 2.0–2.2bn (approx. EUR 170–190m)

Derived from 30.96m shares

Enterprise value

approx. EUR 295–315m (market cap + NIBD incl. leases EUR 123.7m)

Derived

LTM revenue (Jul 2025–Jun 2026)

EUR 121.3m

Derived (FY2025 − H1 2025 + H1 2026)

EV/Sales LTM

approx. 2.5x

Derived

P/B

approx. 1.5x (book equity EUR 116.0m)

Derived

P/E

Not meaningful (loss-making)

—

EV/EBITDA

Not meaningful (LTM operational EBITDA approx. EUR 3.8m, derived)

—

EV per tonne MAB

approx. EUR 12,500–13,300

Derived (23,700t)

Capital Markets

ItemDetail

Number of analysts

4–5 (Simply Wall St, 2025)

Price targets

NOK 90 consensus (Oct 2025, Simply Wall St); range NOK 90–103 (TradingView snapshot, date uncertain) — both likely stale relative to Aug 2026 results

Capital Markets (Annual)

MetricFY2021FY2022FY2023FY2024FY2025

Dividend per share (NOK)

00000

Capital Instruments

InstrumentAmountCurrencyMaturity / terms

Bank borrowings — non-current

119,514

EUR

—

Bank borrowings — current instalments

3,000

EUR

EUR 1.5m semi-annual instalments (EUR 3.0m per year)

Lease liabilities

11,599

NOK 7,188 / ISK 4,411

EUR 4,259 due within 12 months

Cash

(10,385)

Mixed

—

NIBD ex leases

112,130——

NIBD incl. leases

123,729——

Available liquidity

approx. 46,000

—

Q2 2026 presentation

Analyst Conclusions

Management guidance (as of 25 Aug 2026)

ItemGuidance
FY2026 harvest21,300 t (vs 12,671 t in 2025)
Q3 2026 costLower than Q2 2026; 2025 generation harvest from Q3 2026
MAB utilisationImproved, positive cost effect
FY2026 contract shareAbout 10%
FY2026 capexEUR 4.1m (EUR 1.6m spent H1)
US tariffsReduced to 0%
Growth to 26,000 tOn hold pending regulatory clarity
Implied H2 2026 harvestapprox. 12,100 t (derived: 21,300 − 9,201)

TradingView data (date uncertain) showed analysts expecting continued per-share losses in the near term.

Bull case

  1. Volume and cost recovery are underway: H1 2026 harvest +81% YoY and operational EBIT/kg improved from minus EUR 2.23 to minus EUR 0.36; the well-performing 2025 generation should lower cost from Q3 2026, and H2 implies about 12kt — the largest half-year since 2023.

  2. Licence optionality is mispriced: EV of about EUR 12.5–13.3k per tonne of MAB is low relative to Norwegian licence values; re-approval of the 10kt Ísafjarðardjúp sterile licence would add 42% capacity, and the Arnarfjörður licence is now secured for 16 years.

  3. Commercial tailwinds: US tariffs at 0%, Asia demand for large fish (Asia +292% in H1 2026), and Q1 2027 forward prices of EUR 8.20/kg support a strong winter-quarter result; SalMar backing reduces refinancing tail risk.

Bear case

  1. Biology keeps recurring: three consecutive years of material biological incidents (lice 2023, 2024 setbacks, BKD 2026) suggest structurally higher cost and risk than modelled; another bad winter would threaten 2027 volumes.

  2. Balance sheet and covenants: NIBD incl. leases of EUR 124m against negligible trailing operational EBITDA, equity ratio at 43% with a 35% floor, and covenant step-downs at 30 Sep 2026 and 31 Mar 2027 could force further waivers or an equity raise (likely led by SalMar, diluting minorities at depressed prices).

  3. Iceland policy risk is rising, not falling: the aquaculture bill failed, the production fee keeps increasing (+59% YoY in H1 2026), and management has frozen growth — the core equity story of a growth platform is on hold indefinitely.

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Oct–Nov 2026Q3 2026 harvest/results: cost per kg of 2025 generation; 30 Sep covenant test outcome
Q4 2026MAST decision on AquaGen egg-source amendments
Q4 2026–2027Ísafjarðardjúp sterile-salmon licence re-approval
2026–2027Re-introduction and passage of Iceland's aquaculture law; production-fee trajectory
Feb 2027Q4 2026 results; FY2026 delivery vs 21.3kt guidance; 2027 guidance
Q1 2027Laxabraut post-smolt facility completion; 31 Mar 2027 leverage covenant (≤4.50x)
OngoingFish Pool forward prices; North America share post-tariff; any SalMar strategic action

Analyst verdict

Icelandic Salmon is a recovering, sub-scale salmon farmer with high-quality infrastructure trapped in an uncertain regulatory regime. The operating evidence of 2026 is genuinely encouraging: volumes are rebuilding toward a guided 21,300 tonnes, half-year operating cash flow has turned positive, net debt has started to fall, and unit losses have narrowed from more than EUR 2/kg to well under EUR 1/kg despite a further disease incident. The infrastructure — smolt capacity for up to 30,000 tonnes, a 30,000-tonne harvest plant, full certification, and a sales team now attracting third-party volumes — is built for a company considerably larger than today's earnings base. Valuation on asset metrics, at roughly EUR 13,000 per tonne of licensed biomass and about 1.5x book, is undemanding for a SalMar-controlled operator.

Against this, the investment case has lost its main growth leg. Management itself has suspended the 26,000-tonne plan, the legislative process failed in 2026, and the resource tax keeps rising. The balance sheet has absorbed two loss years: leverage has more than doubled since 2023 and the company relies on covenant amendments whose next step-downs fall in September 2026 and March 2027. Biology has been the swing factor in each of the last three years and there is no hard evidence yet that the risk has structurally reduced.

Net assessment: the stock is a call option on (i) a clean 2025-generation harvest in H2 2026 and (ii) Icelandic regulatory normalisation, with SalMar providing a downside backstop but also controlling the terms of any recapitalisation. Investors with tolerance for illiquidity (free float under 5% outside the top 20 holders) may find the asset value compelling, but the near-term risk/reward hinges on the Q3–Q4 2026 cost delivery and covenant outcome. Until those are visible, a neutral stance with a positive bias toward an asset-backed recovery is warranted. This is an analytical assessment, not investment advice.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / backgroundShareholding (30 Jun 2026)

Bjørn Hembre

CEO, Icelandic Salmon AS and Arnarlax ehf.

——

32,900 shares (0.11%) via IVMA AS

Róbert Benedikt Róbertsson

CFO

Appointed during H1 2026 (announced around late 2025/early 2026)

Succeeded interim CFO Edvin Aspli

Not listed

Johnny Indergaard

COO SeaWater

——

650 shares

Rúnar Ingi Pétursson

COO Harvest Plant

——

750 shares

Edvin Aspli (former)

Interim CFO

2025 – H1 2026

Signed Annual Report 2025 release as interim CFO

—

Jónas Heiðar Birgisson (former)

CFO

Until 2025

Led EUR 100m sustainability-linked refinancing (2023)

—

Board of Directors

NameRoleAffiliation / independence assessmentShareholding

Leif-Inge Nordhammer

Chairman

Former President/CEO of SalMar; joined board Oct 2020 — not independent of the majority shareholder

Indirect via minority stake in SalMar

Gustav Witzøe

Board member

Founder of SalMar; indirectly owns approx. 92.6% of Kverva AS, which via Kverva Industries holds about 44.3% of SalMar — not independent (controlling-shareholder representative)

Indirect

Ulrik Steinvik

Board member

SalMar-affiliated (indirect SalMar stake) — not independent of majority holder

Indirect

Kjartan Ólafsson

Board member

Icelandic investor and co-founder-era shareholder; holds 550,000 shares (1.78%) via Berg Fjárfesting/Gyða ehf. — independent of SalMar but a significant shareholder

1.78%

Espen Weyergang Marcussen

Board member

Minority stake via Pactum Vekst AS (2.27% holder) — independent of SalMar

Indirect

Board & Management Changes

DateChangeContext

Spring 2025

"Organizational change in Arnarlax ehf." announced

—
2025

CFO Jónas Heiðar Birgisson departs; Edvin Aspli interim CFO

Interim CFO presented Q2 2025 and signed AR 2025 release

H1 2026

Róbert Benedikt Róbertsson appointed CFO

Permanent CFO appointment; presents Q1 and Q2 2026

18 Jun 2026

All board members re-elected

Board stability

Major Shareholders

RankHolderSharesStake (%)
1

SalMar ASA

16,248,15252.48
2

J.P. Morgan SE (nominee)

2,480,3538.01
3

Íslandsbanki hf. (nominee)

2,355,4137.61
4

Clearstream Banking S.A. (nominee)

2,293,6677.41
5

Holta Invest AS

1,149,1333.71
6

Surfside Holding AS

703,1312.27
7

Pactum Vekst AS

701,9832.27
8

MP Pensjon PK

619,7062.00
9

Nima Invest AS

606,5121.96
10

Roth

599,6611.94

Competitive Landscape

Key Competitors

CompetitorSegment / geographyRelationship to ISLScale indicatorPositioning

Arctic Fish (AFISH)

Iceland, Westfjords sea farming

Direct; Mowi-controlled

29,800 t MAB; 2025 harvest approx. 14.8kt (derived: 10,561 t 9M + 4.2kt Q4); 2026 guidance 17.5kt; NIBD EUR 140m

Larger licence base in Westfjords; new harvest plant

Kaldvik (formerly Ice Fish Farm)

Iceland, East fjords

Direct; Måsøval-backed

2025 harvest 17,105 t; revenue EUR 114.4m; EBIT minus EUR 10.3m

Largest Icelandic producer by 2025 volume

Háafell

Iceland, Ísafjarðardjúp

Direct (local)

—

Small, Westfjords

Land-based Icelandic projects (e.g., First Water, Laxey, Samherji's land-based project)

Iceland, land-based RAS/flow-through

Emerging competitors for Icelandic-origin supply

Not disclosed / early stage

Not subject to sea-licence politics

Mowi ASA

Norway, Scotland, Faroes, Canada, Chile, Iceland (via Arctic Fish)

Global price-setter

World's largest farmer

Integrated incl. value-added processing

SalMar ASA

Norway, Iceland, Scotland (SSF)

Parent and market peer

2025 harvest 300,900 t; Q4 2025 op EBIT NOK 1,834m

Global top-2

Lerøy Seafood Group

Norway

Market competitor

Large integrated

Strong downstream

Grieg Seafood

Norway, Canada

Market competitor

Mid-size

Restructuring footprint

Bakkafrost

Faroe Islands, Scotland

Closest North Atlantic island analogue

Large; premium price

Cold-water island producer, high margins historically

Måsøval

Norway (and Iceland via Kaldvik)

Indirect

Mid-size

—

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricIcelandic SalmonArctic FishKaldvikSalMar (group)

Harvest 2025 (thousand tgw)

12.714.817.1300.9

Revenue 2025 (EUR Mn)

90.0—114.4—

Revenue growth 2025 (%)

-11.3—6.2—

Operational EBIT / EBIT 2025 (EUR Mn)

-18.2-10.3-10.3—

EBIT margin 2025 (%)

-20.2—-9.0—

MAB licences (thousand t)

23.729.8——

2026 volume guidance (thousand tgw)

21.317.5——

Company Snapshot

$101.5M

Revenue

177

Employees

$187M

Market Cap

2009

Founded

Bíldudalur, Iceland

Headquarters

SWOT Analysis

Strengths

  • Integrated value chain: four smolt facilities (capacity for 25–30kt), 23.7kt MAB, 30kt harvest plant, in-house sales (1H 2026 report).
  • Strong parent: SalMar owns 52.48%; three SalMar-affiliated directors including founder Gustav Witzøe (1H 2026 report, Note 4).
  • Certification leadership: 100% ASC-certified sea production; BRCGS-certified plant with AA+ score (AR 2023 summary).
  • Demonstrated earnings power at scale: operational EBIT EUR 36.2m (EUR 2.24/kg) in 2022 on 16.1kt (Q4 2022 release).
  • Core licence secured: 10,000t Arnarfjörður licence renewed for 16 years (May 2026).
  • Cash-flow inflection: H1 2026 operating cash flow +EUR 13.4m vs minus EUR 10.8m in H1 2025; NIBD down EUR 7m in Q2 2026.

Weaknesses

  • Two consecutive loss years: operational EBIT minus EUR 5.9m (2024) and minus EUR 18.2m (2025); net loss EUR 24.8m in 2025.
  • Leverage build-up: NIBD ex-leases EUR 116.6m at YE2025 vs EUR 45.8m at YE2023; equity ratio 43% (30 Jun 2026) vs 64% (2023).
  • Guidance misses: 2025 guidance cut from 15kt to 13kt; actual 12.7kt.
  • Biological volatility: extraordinary items of EUR 3.2m (Q3 2025) and EUR 3.0m (H1 2026); incident-based mortality at three sites in H1 2026.
  • Thin liquidity buffer: cash EUR 10.4m and available liquidity EUR 46m at 30 Jun 2026 versus EUR 4.6m/half-year interest cost.
  • Governance concentration: no clearly independent directors; free float minimal (top-20 = 96.65%).

Opportunities

  • Volume recovery: 2026 guidance 21.3kt (+68% YoY) with lower cost expected from the 2025 generation from Q3 2026.
  • Sterile-salmon licence: re-approval of 10,000t MAB in Ísafjarðardjúp would lift licence capacity to 33,700t (+42%).
  • Arnarfjörður site expansion: application to expand five sites for better MAB utilisation.
  • US market reopening: tariff reduced to 0% in July 2026; North America share already up from 10% (Q1) to 16% (Q2 2026).
  • Asia large-fish demand: Asia revenue +292% in H1 2026 (EUR 13.8m vs EUR 3.5m).
  • Platform monetisation: spare harvest capacity (30kt vs 21kt) and third-party sales outsourcing.

Threats

  • Regulatory uncertainty: aquaculture bill not passed in Q2 2026; growth plan to 26kt frozen.
  • Fiscal pressure: production tax up 59% YoY in H1 2026 (EUR 2.7m vs 1.7m).
  • Disease: BKD in 2024 generation (2026), lice crisis (2023); ISA present in the region historically.
  • Price risk: forward prices for Q3 2026 at EUR 5.85/kg, below the EUR 6.28 a year earlier; low 6–10% contract cover.
  • Covenant step-downs: ICR ≥2.50x and NIBD/EBITDA ≤5.00x from 30 Sep 2026; ≤4.50x from 31 Mar 2027.
  • Environmental/social licence: escape incident fine (ISK 120m, under appeal) and public opposition to open-net farming in Iceland.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
25 Apr 2025Annual Report 2024 published (release text carries a "2024" date typo); CEO cites 26,000 t capacity readinessGrowth narrative reaffirmed
May 2025Q1 2025 results ("Challenging first quarter"): harvest about 1.1kt, operational EBIT about minus EUR 3.0m (derived)Biological legacy of 2024
Spring 2025Organisational change in Arnarlax ehf. announcedManagement restructuring
Apr 2025 onwardsUS tariffs imposed on Icelandic importsNorth America share falls
18 Jun 2025AGM; no dividendCapital preservation
2025Interim CFO Edvin Aspli replaces CFO Jónas Heiðar BirgissonFinance leadership change
21 Aug 2025Q2 2025: harvest 4.0kt, operational EBIT minus EUR 8.3m (minus EUR 2.09/kg)High-cost 2023 generation
Sep 2025Bank facility extended and amended; ICR and leverage covenants waived, new step-down covenantsAverts covenant breach
Q3 20252025 harvest guidance lowered to 13kt (from 15kt)Credibility hit
Oct 2025Harvest of 2024 generation beginsExpected lower cost
Nov 2025Q3 2025: harvest 3.8kt, revenue EUR 25.1m, operational EBIT minus EUR 9.4m incl. EUR 3.2m extraordinary items; 2026 guidance 21kt; liquidity EUR 52mTrough quarter
Late 2025/early 2026Róbert Róbertsson appointed CFOPermanent finance leadership
Jan 2026SalMar trading update: Icelandic Salmon Q4 harvest 3.8ktVolume confirmation
10 Feb 2026Q4 2025: operational EBIT +EUR 2.6m (EUR 0.70/kg); FY2025 harvest 12.7kt; about 300 t pushed into Jan 2026First positive quarter since Q4 2024
Feb 20262026 guidance set at 21.3kt+68% volume growth guided
27 Mar 2026Annual Report 2025 published: revenue EUR 90.0m, net loss EUR 24.8mFormal close of loss year
20 May 2026Q1 2026: harvest 3.7kt, operational EBIT about break-even (minus EUR 0.02/kg)Recovery momentum
May 2026Arnarfjörður 10,000 t licence renewed for 16 years by MASTDe-risks core licence
H1 2026Application filed to expand five Arnarfjörður sitesPotential MAB utilisation upside
H1 2026BKD in 2024 generation at one site; site fully harvested; EUR 2.9–3.0m extraordinary costs; incidents at three sitesBiology remains the key risk
H1 2026Third-party producer outsources sales to ArnarlaxNew commercial revenue stream
Q2 2026Proposed aquaculture law presented to the Alþingi but not passedRegulatory uncertainty persists
Jun 2026FLS delicing service vessel operationalLice-control capability
18 Jun 2026AGM: board re-elected; authority to acquire treasury shares up to 10% of share capital; no dividend for 2025Governance continuity
Jul 2026US tariffs on Icelandic salmon reduced to 0%Supports North America pricing
25 Aug 2026Q2 2026: revenue EUR 39.9m, harvest 5.5kt, operational EBIT minus EUR 3.2m; price EUR 0.58/kg higher YoY; NIBD incl. leases EUR 123.7m; equity ratio 43%; liquidity EUR 46mImprovement but still loss-making
25 Aug 2026Growth plan to 26,000 t put on hold; capex reduced; management criticises "excessive, non-sustainable" tax levelStrategic pause
8 Sep 2026MAST publishes proposed licence amendments to allow AquaGen eggs at Arnarlax-group facilities; comments due 7 Oct 2026Supply-chain diversification
30 Sep 2026Step-down covenant test date (ICR ≥2.50x; NIBD/EBITDA ≤5.00x)Key financing monitorable
Oct–Nov 2026 (expected)Q3 2026 results/SalMar Q3 trading update — not yet published as of 18 Oct 2026First quarter with 2025 generation harvest

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue fell from EUR 90.8 Mn in FY2021 to EUR 90 Mn in FY2025.
Icelandic Salmon AS — Income Statement: Revenue & Gross Profit
Series (EUR Mn)FY2021FY2022FY2023FY2024FY2025
Revenue90.8157.6164.8101.590
Gross profit after COGS————31.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Icelandic Salmon AS — Condensed Consolidated Interim Financial Statements, First Half 2026 (25 Aug 2026) (attachment.news.eu.nasdaq.com)
  2. Icelandic Salmon AS — Quarterly Presentation 2Q 2026 (25 Aug 2026) (attachment.news.eu.nasdaq.com)
  3. Icelandic Salmon — Q2 2026 release (Inderes / Börskollen) · borskollen.se
  4. Quartr — Icelandic Salmon Q2 2026 earnings summary (quartr.com)
  5. Icelandic Salmon — Annual Report 2025 release (Inderes) (inderes.se)
  6. Financial Filings — FY2025 headline figures (financialfilings.com)
  7. Icelandic Salmon — Annual Report 2024 release (inderes.dk)
  8. Icelandic Salmon — Annual Report 2023 release and summary · sustainabilityreports.com
  9. Icelandic Salmon — Q4 2022 results release and presentation (live.euronext.com)
  10. SeafoodSource — Q4 2025 results (seafoodsource.com)
  11. SeafoodSource — Q4 2024 results (seafoodsource.com)
  12. IntraFish — FY2025 harvest (intrafish.com)
  13. Baird Maritime — Q3 2025 results (bairdmaritime.com)
  14. Baird Maritime — Q4 2024 results (bairdmaritime.com)
  15. WeAreAquaculture — Q4 2024 / financing (weareaquaculture.com)
  16. WeAreAquaculture — EUR 100m sustainability-linked facility (weareaquaculture.com)
  17. WeAreAquaculture — Ísafjarðardjúp sterile licence (weareaquaculture.com)
  18. WeAreAquaculture — Q3 2024 and licence revocation (weareaquaculture.com)
  19. WeAreAquaculture — MAST escape fine (weareaquaculture.com)
  20. Fish Farmer — Q3 2023 / lice impact (fishfarmermagazine.com)
  21. Fish Farming Expert — 2020 private placement (fishfarmingexpert.com)
  22. Salmon Business — name change and placement · salmonbusiness.com
  23. Salmon Business — AquaGen licence amendments (10 Sep 2026) (salmonbusiness.com)
  24. Salmon Business — SalMar Q4 2025 and harvest data · salmonbusiness.com
  25. Salmon Business — Kaldvik 2025 (salmonbusiness.com)
  26. Baird Maritime / Inderes — Arctic Fish Q3 and Q4 2025 · inderes.dk
  27. Market data: Simply Wall St ( roic.ai ( TradingView ( Alphaspread ( PitchBook ( TipRanks (: simplywall.st · roic.ai · tradingview.com · alphaspread.com · pitchbook.com · tipranks.com
  28. MFN calendar (dividends, report dates) (mfn.se)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.